Annual Drug Patent Expirations for TRULANCE
Trulance is a drug marketed by Salix and is included in one NDA. It is available from two suppliers. There are eight patents protecting this drug.
Drug patent litigation for TRULANCE.
This drug has fifty-eight patent family members in fifteen countries.
The generic ingredient in TRULANCE is plecanatide. Two suppliers are listed for this compound. Additional details are available on the plecanatide profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
